Drug intelligence / Profile preview

green tea polyphenol formulations

Development stage
Unknown
Lead developer
Topix Pharmaceuticals
Modality
Small Molecules
Administration
Topical
01

Overview

Green tea polyphenol formulations developed by Topix Pharmaceuticals are topical cosmeceutical products designed to treat sensitive skin and reduce oxidative stress. These formulations contain high concentrations of purified green tea polyphenols (GTP), particularly epigallocatechin-3-gallate (EGCG), which is the most active component. The technology focuses on stabilizing these polyphenols to maintain their potency in topical vehicles like creams and serums. Mechanistically, GTPs act as powerful antioxidants that neutralize reactive oxygen species (ROS) generated by UV radiation and environmental pollutants, while also providing anti-inflammatory effects by modulating signaling pathways such as NF-kappaB. These products are primarily indicated for soothing redness, managing rosacea-prone skin, and providing anti-aging benefits.

Brand names
Replenix
Other names
green tea polyphenolsGTPepigallocatechin-3-gallateepigallocatechin3-gallateepigallocatechin 3-gallate
02

Targets

MEKTP53 (Cellular Tumor Antigen p53 R175H)MMP12 (Macrophage Metalloelastase)26S proteasomeBCL2L1 (B-cell lymphoma-extra large protein)

Beyond the preview

Go deeper on green tea polyphenol formulations.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on green tea polyphenol formulations.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call